Genmab A/S (CPH:GMAB)
Denmark · Delayed Price · Currency is DKK 2,156.00
-11.00 (-0.51%)
Aug 28, 2026, 4:59 PM CET
Genmab Market Cap
Genmab has a market cap or net worth of 128.72 billion as of August 28, 2026. Its market cap has increased by 31.87% in one year.
Market Cap
128.72B
Enterprise Value
153.34B
Revenue
27.03B
Ranking
n/a
PE Ratio
26.04
Stock Price
2,156.00
ChartMarket Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 3.68B to 128.72B, an increase of 3,393.74%. That is a compound annual growth rate of 14.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 128.72B | 3.09% |
| Dec 30, 2025 | 124.86B | 31.70% |
| Dec 30, 2024 | 94.81B | -32.65% |
| Dec 29, 2023 | 140.77B | -26.77% |
| Dec 30, 2022 | 192.23B | 11.72% |
| Dec 30, 2021 | 172.06B | 6.80% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.31T |
| Coloplast | 103.35B |
| Demant | 60.32B |
| ALK-Abelló | 47.08B |
| H. Lundbeck | 41.38B |
| Zealand Pharma | 21.59B |
| Ambu A/S | 18.51B |
| Bavarian Nordic | 16.13B |